egc-encoded superantigens from Staphylococcus aureus are neutralized by human sera much less efficiently than are classical staphylococcal enterotoxins or toxic shock syndrome toxin

被引:111
作者
Holtfreter, S
Bauer, K
Thomas, D
Feig, C
Lorenz, V
Roschack, K
Friebe, E
Selleng, K
Lövenich, S
Greve, T
Greinacher, A
Panzig, B
Engelmann, S
Lina, G
Bröker, BM
机构
[1] Univ Greifswald, Inst Immunol & Transfusionsmed, D-17487 Greifswald, Germany
[2] Univ Greifswald, Inst Mikrobiol, Abt Molekularbiol, D-17487 Greifswald, Germany
[3] Univ Greifswald, Friedrich Loeffler Inst Med Mikrobiol, D-17487 Greifswald, Germany
[4] IFR62, INSERM, E 0230, Ctr Natl Ref Staphylocoques, Lyon, France
关键词
D O I
10.1128/IAI.72.7.4061-4071.2004
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
PCR was employed to determine the presence of all known superantigen genes (sea, seq, and tst) and of the exotoxin-like gene cluster (set) in 40 Staphylococcus aureus isolates from blood cultures and throat swabs; 28 isolates harbored superantigen genes, five on average, and this strictly correlated with their ability to stimulate T-cell proliferation. In contrast, the set gene cluster was detected in every S. aureus strain, suggesting a nonredundant function for these genes which is different from T-cell activation. No more than 10% of normal human serum samples inhibited the T-cell stimulation elicited by egc-encoded enterotoxins (staphylococcal enterotoxins G, 1, M, N, and 0), whereas between 32 and 86% neutralized the classical superantigens. Similarly, intravenous human immunoglobulin G preparations inhibited egc-encoded superantigens with 10- to 100-fold-reduced potency compared with the classical enterotoxins. Thus, there are surprisingly large gaps in the capacity of human serum samples to neutralize S. aureus superantigens.
引用
收藏
页码:4061 / 4071
页数:11
相关论文
共 42 条
[1]   Superantigen antagonist protects against lethal shock and defines a new domain for T-cell activation [J].
Arad, G ;
Levy, R ;
Hillman, D ;
Kaempfer, R .
NATURE MEDICINE, 2000, 6 (04) :414-421
[2]   The three-dimensional structure of a superantigen-like protein, SET3, from a pathogenicity island of the Staphylococcus aureus genome [J].
Arcus, VL ;
Langley, R ;
Proft, T ;
Fraser, JD ;
Baker, EN .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (35) :32274-32281
[3]   Genome and virulence determinants of high virulence community-acquired MRSA [J].
Baba, T ;
Takeuchi, F ;
Kuroda, M ;
Yuzawa, H ;
Aoki, K ;
Oguchi, A ;
Nagai, Y ;
Iwama, N ;
Asano, K ;
Naimi, T ;
Kuroda, H ;
Cui, L ;
Yamamoto, K ;
Hiramatsu, K .
LANCET, 2002, 359 (9320) :1819-1827
[4]   Staphylococcus aureus express unique superantigens depending on the tissue source [J].
Banks, MC ;
Kamel, NS ;
Zabriskie, JB ;
Larone, DH ;
Ursea, D ;
Posnett, DN .
JOURNAL OF INFECTIOUS DISEASES, 2003, 187 (01) :77-86
[5]   Structure and function of streptococcal and staphylococcal superantigens in septic shock [J].
Bannan, J ;
Visvanathan, K ;
Zabriskie, JB .
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 1999, 13 (02) :387-+
[6]  
BENTLEY M, 1992, CHEM IMMUNOL, V55, P1
[7]   Superantigen and endotoxin synergize in the induction of lethal shock [J].
Blank, C ;
Luz, A ;
Bendigs, S ;
Erdmann, A ;
Wagner, H ;
Heeg, K .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (04) :825-833
[8]   Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome:: A European randomized, double-blind, placebo-controlled trial [J].
Darenberg, J ;
Ihendyane, N ;
Sjölin, J ;
Aufwerber, E ;
Haidl, S ;
Follin, P ;
Andersson, J ;
Norrby-Teglund, A .
CLINICAL INFECTIOUS DISEASES, 2003, 37 (03) :333-340
[9]   Role of T cells and gamma interferon during induction of hypersensitivity to lipopolysaccharide by toxic shock syndrome toxin 1 in mice [J].
Dinges, MM ;
Schlievert, PM .
INFECTION AND IMMUNITY, 2001, 69 (03) :1256-1264
[10]   Genome diversification in Staphylococcus aureus:: Molecular evolution of a highly variable chromosomal region encoding the staphylococcal exotoxin-like family of proteins [J].
Fitzgerald, JR ;
Reid, SD ;
Ruotsalainen, E ;
Tripp, TJ ;
Liu, MY ;
Cole, R ;
Kuusela, P ;
Schlievert, PM ;
Järvinen, A ;
Musser, JM .
INFECTION AND IMMUNITY, 2003, 71 (05) :2827-2838